Formulations of bioreachable dopants for liquid crystals
US-2023203378-A1 · Jun 29, 2023 · US
US11814563B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11814563-B2 |
| Application number | US-201917299777-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 6, 2019 |
| Priority date | Dec 7, 2018 |
| Publication date | Nov 14, 2023 |
| Grant date | Nov 14, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure discusses chiral dopants for liquid-crystalline materials. Chiral dopants can be bioreachable compounds, i.e. compounds produced from microbes through fermentation. Chiral dopants can also include bioreachable materials that are further modified by chemical synthetic steps. Chiral dopants as discussed herein can include biomolecules such as glycyrrhetinic acid (1), S-naringenin (2), shikimic acid (3), alpha-phellandrene (4), betulin (5), malic acid (6), valencene (7), or nootkatone (8), and any stereoisomers or chemically modified derivatives thereof. The disclosure further shows optical properties of such compounds in a liquid-crystalline material.
Opening claim text (preview).
What is claimed is: 1. A liquid-crystalline material comprising at least one chiral dopant selected from the group consisting of the structures wherein R 1 , R 2 , R 3 , and R 4 are each independently hydrogen, an aliphatic moiety, an aryl moiety, an arylalkylene moiety, an alkyl arylene moiety, an alkanoyl moiety, an arylalkanoyl moiety, or any halogenated derivative of the foregoing moieties, and wherein Z is selected from C(H)R 5 , —CR 5 ═CR 5 —, O, S, or NRs, wherein R 5 is independently hydrogen, an aliphatic moiety, an aryl moiety, an arylalkylene moiety, an alkyl arylene moiety, an alkanoyl moiety, an arylalkanoyl moiety, or any halogenated derivative of the foregoing moieties, and a nematic or a nematogenic substance. 2. The liquid-crystalline material according to claim 1 , wherein the at least one chiral dopant is present in an amount of at least 0.001 wt %, based on the weight of the liquid-crystalline material. 3. The liquid-crystalline material according to claim 1 , wherein the at least one chiral dopant is present in an amount of not greater than 20 wt %, based on the weight of the liquid-crystalline material. 4. The liquid-crystalline material according to claim 1 , further comprising at least one polymerizable mesogenic compound having at least one polymerizable functional group. 5. The liquid-crystalline material according to claim 4 , wherein the at least one polymerizable functional group includes an epoxy group, a vinyl group, an allyl group, an acrylate, a methacrylate, an isoprene group, an alpha-amino carboxylate, or any combination thereof. 6. The liquid-crystalline material according to claim 1 , wherein the nematic or the nematogenic substance is selected from azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl benzoates, cyclohexyl benzoates, phenyl esters of cyclohexanecarboxylic acid, cyclohexyl esters of cyclohexanecarboxylic acid, phenyl esters of cyclohexylbenzoic acid, cyclohexyl esters of cyclohexylbenzoic acid, phenyl esters of cyclohexylcyclohexanecarboxylic acid, cyclohexyl esters of cyclohexylcyclohexanecarboxylic acid, cyclohexylphenyl esters of benzoic acid, cyclohexylphenyl esters of cyclohexanecarboxylic acid, cyclohexylphenyl esters of cyclohexylcyclohexanecarboxylic acid, phenylcyclohexanes, cyclohexylbiphenyls, phenylcyclohexylcyclohexanes, cyclohexylcyclohexanes, cyclohexylcyclohexenes, cyclohexylcyclohexylcyclohexenes, 1,4-bis-cyclohexylbenzenes, 4,4′-bis-cyclohexylbiphenyls, phenylpyrimidines, cyclohexylpyrimidines, phenylpyridines, cyclohexylpyridines, phenylpyridazines, cyclohexylpyridazines, phenyldioxanes, cyclohexyldioxanes, phenyl-1,3-dithianes, cyclohexyl-1,3-dithianes, 1,2-diphenylethanes, 1,2-dicyclohexylethanes, 1-phenyl-2-cyclohexylethanes, 1-cyclohexyl-2-(4-phenylcyclohexyl) ethanes, 1-cyclohexyl-2-biphenylethanes, 1-phenyl-2-cyclohexylphenylethanes, halogenated stilbenes, benzyl phenyl ether, tolanes, substituted cinnamic acids, or any combination thereof.
Heterocyclic compounds · CPC title
Optically active dopants; chiral dopants · CPC title
based on a change of the texture state of a cholesteric liquid crystal · CPC title
Filters (polarising elements G02B5/30) · CPC title
characterised by optical, electrical or physical properties of the components, in general · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.